Press Releases
Quaker Houghton Announces Third Quarter 2019 Results
On a reported basis, the Company's third quarter of 2019 net loss was
Third Quarter 2019 Consolidated Results
Net sales were
Gross profit in the third quarter of 2019 increased
Selling, general and administrative expenses ("SG&A") in the third quarter of 2019 increased
During the third quarter of 2019, the Company incurred
The Company initiated a restructuring program and recorded restructuring expense during the third quarter of 2019 of
Operating loss in the third quarter of 2019 was
The Company had other income, net, of
Interest expense, net, increased
The Company's effective tax rates for the third quarters of 2019 and 2018 were 27.6% and 18.5%, respectively. The current quarter effective tax rate was affected by the Combination and other acquisition-related charges and restructuring expenses incurred which resulted in a loss before taxes. Excluding the impact of these and other non-core items in each quarter, the Company estimates that its effective tax rates for the third quarters of 2019 and 2018 would have been approximately 20% and 22%, respectively. The Company's lower current quarter effective tax rate was due primarily to a cumulative year-to-date tax benefit recorded during the third quarter of 2019 as a result of one of its subsidiaries receiving approval for the renewal of a concessionary 15% tax rate compared to its 25% statutory tax rate. The concessionary tax rate was available to the Company's subsidiary during all quarters of 2018.
Equity in net income of associated companies increased
Foreign exchange positively affected the Company's third quarter of 2019 earnings by approximately 1% or
Balance Sheet and Cash Flow Highlights
The Company had net operating cash flow of
The Company paid approximately
Concurrent with closing of the Combination on
The Company has paid
Subsequent Event
As previously announced, subsequent to the date of the unaudited financial statements included herein, on
Non-GAAP and Pro Forma Measures
The information included in this public release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, non-GAAP operating income, non-GAAP net income, non-GAAP earnings per diluted share and pro forma adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net - adjusted, and taxes on income before equity in net income of associated companies - adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
During the first quarter of 2019, the Company updated its calculation methodology to include the use of interest expense net of interest income in the reconciliation of EBITDA and adjusted EBITDA, compared to its historical use of only interest expense, and also to include the non-service component of the Company's pension and postretirement benefit costs in the reconciliation of adjusted EBITDA, non-GAAP net income attributable to
As it relates to the full year expected results for the Company's acquisition of the operating divisions of Norman Hay plc, described above, as well as the Company's forward looking guidance for the fourth quarter of 2019, the Company has not provided guidance for GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort. These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income, such as Combination and other acquisition-related expenses and restructuring expenses, as well as income taxes. These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period.
The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||
2019 |
2018 |
2019 |
2018 |
||||
Operating (loss) income |
$ (14,502) |
$ 24,919 |
$ 25,858 |
$ 67,713 |
|||
Fair value step up of Houghton inventory sold |
10,214 |
— |
10,214 |
— |
|||
Houghton combination and other |
14,702 |
2,904 |
23,789 |
12,404 |
|||
acquisition-related expenses (a) |
|||||||
Restructuring expense |
24,045 |
— |
24,045 |
— |
|||
Charges related to the settlement of a non-core |
— |
— |
384 |
— |
|||
equipment sale |
|||||||
Non-GAAP operating income |
$ 34,459 |
$ 27,823 |
$ 84,290 |
$ 80,117 |
|||
Non-GAAP operating margin (%) |
10.6% |
12.5% |
11.4% |
12.2% |
|||
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||
2019 |
2018 |
2019 |
2018 |
||||
Net (loss) income attributable to Quaker Chemical |
$ (13,053) |
$ 19,690 |
$ 16,382 |
$ 51,668 |
|||
Depreciation and amortization (b) |
14,312 |
4,883 |
24,014 |
14,911 |
|||
Interest expense, net (c) |
6,102 |
989 |
7,611 |
3,223 |
|||
Taxes on income before equity in net income |
(5,633) |
4,330 |
4,096 |
13,554 |
|||
of associated companies (d) |
|||||||
EBITDA |
$ 1,728 |
$ 29,892 |
$ 52,103 |
$ 83,356 |
|||
Equity income in a captive insurance company |
(524) |
(440) |
(1,260) |
(1,083) |
|||
Fair value step up of Houghton inventory sold |
10,214 |
— |
10,214 |
— |
|||
Houghton combination and other |
14,702 |
2,904 |
23,789 |
11,794 |
|||
acquisition-related expenses (a) |
|||||||
Restructuring expense |
24,045 |
— |
24,045 |
— |
|||
Pension and postretirement benefit costs, |
513 |
568 |
2,304 |
1,713 |
|||
non-service components |
|||||||
Charges related to the settlement of a non-core |
— |
— |
384 |
— |
|||
equipment sale |
|||||||
Gain on liquidation of an inactive legal entity |
— |
(446) |
— |
(446) |
|||
Currency conversion impacts of hyper- |
728 |
520 |
891 |
764 |
|||
inflationary economies |
|||||||
Adjusted EBITDA |
$ 51,406 |
$ 32,998 |
$ 112,470 |
$ 96,098 |
|||
Adjusted EBITDA margin (%) |
15.8% |
14.9% |
15.2 % |
14.6% |
|||
Adjusted EBITDA |
$ 51,406 |
$ 32,998 |
$ 112,470 |
$ 96,098 |
|||
Less: Depreciation and amortization (b) |
14,312 |
4,883 |
24,014 |
14,911 |
|||
Less: Interest expense, net - adjusted (c) |
5,747 |
131 |
5,531 |
637 |
|||
Less: Taxes on income before equity in net |
6,086 |
6,223 |
17,913 |
18,650 |
|||
income of associated companies – adjusted (d) |
|||||||
Non-GAAP net income |
$ 25,261 |
$ 21,761 |
$ 65,012 |
$ 61,900 |
|||
Three Months Ended |
Nine Months Ended September 30, |
||||||
2019 |
2018 |
2019 |
2018 |
||||
GAAP (loss) earnings per diluted share attributable to |
$ (0.80) |
$ 1.47 |
$ 1.14 |
$ 3.87 |
|||
Equity income in a captive insurance company per |
(0.03) |
(0.03) |
(0.09) |
(0.08) |
|||
Fair value step up of Houghton inventory sold per diluted |
0.47 |
— |
0.53 |
— |
|||
Houghton combination and other acquisition-related |
0.75 |
0.23 |
1.50 |
0.89 |
|||
Restructuring expense per diluted share |
1.13 |
— |
1.28 |
— |
|||
Transition tax adjustments per diluted share (d) |
(0.03) |
(0.08) |
(0.03) |
(0.17) |
|||
Pension and postretirement benefit costs, non-service |
0.02 |
0.03 |
0.12 |
0.09 |
|||
Charges related to the settlement of a non-core |
— |
— |
0.02 |
— |
|||
Gain on liquidation of an inactive legal entity per diluted |
— |
(0.03) |
— |
(0.03) |
|||
Currency conversion impacts of hyper-inflationary |
0.05 |
0.04 |
0.06 |
0.06 |
|||
Non-GAAP earnings per diluted share (e) |
$ 1.56 |
$ 1.63 |
$ 4.53 |
$ 4.63 |
(a) |
Houghton combination and other acquisition-related expenses during the nine months ended September 30, 2018 includes a $0.6 million gain on the sale of an available-for-sale asset recorded below operating income, within other income (expense), net. |
(b) |
Depreciation and amortization for both the three and nine months ended September 30, 2019 includes $0.1 million of amortization expense recorded within equity in net income of associated companies, attributable to the amortization of the fair value step up for Houghton's 50% interest in a joint venture in Korea as a result of required purchase accounting. |
(c) |
Interest expense, net – adjusted excludes $0.4 million and $2.1 million for the three and nine months ended September 30, 2019, respectively, and $0.9 and $2.6 million for the three and nine months ended September 30, 2018, respectively, of interest costs the Company incurred to maintain the bank commitment to finance the Combination, prior to executing the New Credit Facility and closing the Combination on August 1, 2019. |
(d) |
Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net (loss) income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. In addition, this also includes transition tax adjustments of $0.4 million during both the three and nine months ended September 30, 2019, as well as $1.1 million and $2.3 million, during the three and nine months ended September 30, 2018, respectively. |
(e) |
The Company's calculation of GAAP and non-GAAP (loss) earnings per diluted share attributable to Quaker Chemical Corporation common shareholders for the three and nine months ended September 30, 2019 was impacted by the 4.3 million share issuance in connection with closing the Combination, noted above, as well as the variability of its reported earnings, which was primarily due to the Combination and other acquisition-related charges and restructuring expenses incurred. Therefore, the per diluted share result for each of the first three quarters of 2019, as reported on a standalone basis, may not add up to the per diluted share result for the nine months ended September 30, 2019. |
The Company has provided certain unaudited pro forma financial information in this press release. The unaudited pro forma financial information is based on the historical consolidated financial statements and results of both Quaker, as reported, and Houghton, and has been prepared to illustrate the effects of the Combination. The unaudited pro forma financial information has been presented for informational purposes only and is not necessarily indicative of Quaker Houghton's past results of operations, nor is it indicative of the future operating results of Quaker Houghton and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following schedules present the Company's unaudited pro forma financial information for net sales, as well as net (loss) income attributable to Quaker Houghton and the applicable reconciliation to EBITDA and Adjusted EBITDA on a pro forma non-GAAP basis (dollars in millions unless otherwise noted):
Three months ended September 30, 2019 (a) |
|||||||||
As Reported |
Houghton |
Divestitures(b) |
Other (c) |
Pro Forma * |
|||||
Net sales |
$ 325 |
$ 72 |
$ (9) |
$ (2) |
$ 386 |
||||
Net (loss) income attributable to Quaker |
$ (13) |
$ (7) |
$ (1) |
$ 2 |
$ (20) |
||||
Depreciation and amortization |
14 |
4 |
— |
0 |
19 |
||||
Interest expense, net |
6 |
5 |
— |
(2) |
9 |
||||
Taxes on (loss) income (d) |
(6) |
4 |
(0) |
0 |
(2) |
||||
EBITDA * |
2 |
6 |
(1) |
0 |
7 |
||||
Combination and other acquisition- |
15 |
40 |
— |
— |
55 |
||||
Gain on the sale of divested assets |
— |
(35) |
— |
— |
(35) |
||||
Fair value step up of Houghton |
10 |
— |
— |
— |
10 |
||||
Restructuring expense |
24 |
— |
— |
— |
24 |
||||
Other addbacks (e) |
1 |
0 |
— |
— |
1 |
||||
Adjusted EBITDA * |
$ 51 |
$ 11 |
$ (1) |
$ 0 |
$ 61 |
||||
Adjusted EBITDA margin * (%) |
16% |
15% |
13% |
-5% |
16% |
||||
Three months ended September 30, 2018 (a) |
|||||||||
As Reported |
Houghton |
Divestitures(b) |
Other (c) |
Pro Forma * |
|||||
Net sales |
$ 222 |
$ 213 |
$ (13) |
$ (5) |
$ 417 |
||||
Net income attributable to Quaker |
$ 20 |
$ 1 |
$ (3) |
$ 4 |
$ 23 |
||||
Depreciation and amortization |
5 |
13 |
— |
1 |
19 |
||||
Interest expense, net |
1 |
14 |
— |
(6) |
9 |
||||
Taxes on income (d) |
4 |
(3) |
(1) |
1 |
2 |
||||
EBITDA * |
30 |
26 |
(3) |
0 |
53 |
||||
Combination and other acquisition- |
3 |
3 |
— |
— |
5 |
||||
Other addbacks (e) |
0 |
1 |
— |
— |
1 |
||||
Adjusted EBITDA * |
$ 33 |
$ 29 |
$ (3) |
$ 0 |
$ 59 |
||||
Adjusted EBITDA margin * (%) |
15% |
14% |
25% |
-4% |
14% |
||||
Trailing twelve months ended September 30, 2019 (a) |
|||||||||
As Reported |
Houghton |
Divestitures(b) |
Other (c) |
Pro Forma * |
|||||
Net income (loss) attributable to Quaker |
$ 24 |
$ (7) |
$ (9) |
$ 13 |
$ 21 |
||||
Depreciation and amortization |
29 |
44 |
— |
5 |
78 |
||||
Interest expense, net |
8 |
48 |
— |
(21) |
35 |
||||
Taxes on income (d) |
16 |
4 |
(2) |
4 |
21 |
||||
EBITDA * |
77 |
89 |
(11) |
0 |
154 |
||||
Combination and other acquisition- |
28 |
46 |
— |
— |
74 |
||||
Gain on the sale of divested assets |
— |
(35) |
— |
— |
(35) |
||||
Fair value step up of Houghton |
10 |
— |
— |
— |
10 |
||||
Restructuring expense |
24 |
— |
— |
— |
24 |
||||
Other addbacks (e) |
3 |
0 |
— |
— |
3 |
||||
Adjusted EBITDA * |
$ 142 |
$ 99 |
$ (11) |
$ 0 |
$ 230 |
||||
Adjusted EBITDA margin * (%) |
15% |
15% |
25% |
0% |
15% |
||||
* Certain amounts may not calculate due to rounding, including EBITDA, Adjusted EBITDA, Adjusted EBITDA margin (%) as well as the total pro forma financial results as presented for combined Quaker Houghton |
(a) |
As reported results for the three months ended September 30, 2019 include two months of Houghton's operations as the Combination closed on August 1, 2019. The Houghton results for the three months ended September 30, 2019 reflect only the results for the month of July 2019, prior to closing of the Combination. Comparatively, the as reported results for the three months ended September 30, 2018 include only Quaker's historical as reported results, while Houghton results include all three months. Similar to the as reported results for the three months ended September 30, 2019, the as reported results for the trailing twelve months ended September 30, 2019 include two months of Houghton's operations, while Houghton reflects ten months of results for the period from October 1, 2018 through July 31, 2019. |
(b) |
Divestitures includes the elimination of results associated with the divested product lines. |
(c) |
Other includes: (i) additional depreciation and amortization expense based on the initial estimates of fair value step up and estimated useful lives of depreciable fixed assets, definite-lived intangible assets and investment in associated companies acquired; (ii) adoption of required accounting guidance and alignment of related accounting policies; (iii) elimination of transactions between Quaker and Houghton; and (iv) an adjustment to interest expense, net, to reflect the impact of the new financing and capital structure of the combined Company. |
(d) |
Taxes on income related to the Divestiture and Other reflect each tax effected at the U.S. tax rate of 21%. |
(e) |
Other addbacks includes: (i) Equity income in a captive insurance company; (ii) Pension and postretirement benefit costs, non-service components; (iii) Currency conversion impacts of hyper-inflationary economies; (iv) Gain on liquidation of an inactive legal entity; (v) Affiliate management fees; and (vi) other non-recurring miscellaneous charges. |
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, including but not limited to our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan" or similar expressions. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. Other factors could also adversely affect us, including those related to the Combination and other acquisitions and the integration of the combined company as well as other acquired businesses. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control. These risks, uncertainties, and possible inaccurate assumptions relevant to the Company's business could cause its actual results to differ materially from expected and historical results. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2018, as amended, and in our quarterly and other reports filed from time to time with the SEC. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced, the Company's investor conference call to discuss its third quarter performance is scheduled for
About Quaker Houghton
Quaker Houghton is a global leader in industrial process fluids. With a robust presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With 4,000 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in
Quaker Chemical Corporation |
|||||||
Condensed Consolidated Statements of Operations |
|||||||
(Dollars in thousands, except share and per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2019 |
2018 |
2019 |
2018 |
||||
Net sales |
$ 325,130 |
$ 222,022 |
$ 742,209 |
$ 656,039 |
|||
Cost of goods sold |
220,073 |
140,929 |
486,224 |
418,562 |
|||
Gross profit |
105,057 |
81,093 |
255,985 |
237,477 |
|||
% |
32.3% |
36.5% |
34.5% |
36.2% |
|||
Selling, general and administrative expenses |
80,812 |
53,270 |
182,293 |
157,360 |
|||
Restructuring and related activities |
24,045 |
- |
24,045 |
- |
|||
Combination and other acquisition-related expenses |
14,702 |
2,904 |
23,789 |
12,404 |
|||
Operating (loss) income |
(14,502) |
24,919 |
25,858 |
67,713 |
|||
% |
-4.5% |
11.2% |
3.5% |
10.3% |
|||
Other income (expense), net |
203 |
(523) |
(389) |
(631) |
|||
Interest expense, net |
(6,102) |
(989) |
(7,611) |
(3,223) |
|||
(Loss) income before taxes and equity in net income of associated |
(20,401) |
23,407 |
17,858 |
63,859 |
|||
Taxes on income before equity in net income of associated companies |
(5,633) |
4,330 |
4,096 |
13,554 |
|||
(Loss) income before equity in net income of associated companies |
(14,768) |
19,077 |
13,762 |
50,305 |
|||
Equity in net income of associated companies |
1,787 |
694 |
2,806 |
1,623 |
|||
Net (loss) income |
(12,981) |
19,771 |
16,568 |
51,928 |
|||
Less: Net income attributable to noncontrolling interest |
72 |
81 |
186 |
260 |
|||
Net (loss) income attributable to Quaker Chemical Corporation |
$ (13,053) |
$ 19,690 |
$ 16,382 |
$ 51,668 |
|||
% |
-4.0% |
8.9% |
2.2% |
7.9% |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
16,185,724 |
13,278,259 |
14,271,121 |
13,263,417 |
|||
Diluted weighted average common shares outstanding |
16,218,226 |
13,315,541 |
14,313,971 |
13,297,345 |
|||
Net (loss) income attributable to Quaker Chemical Corporation common |
$ (0.80) |
$ 1.48 |
$ 1.15 |
$ 3.88 |
|||
Net (loss) income attributable to Quaker Chemical Corporation common |
$ (0.80) |
$ 1.47 |
$ 1.14 |
$ 3.87 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
(Unaudited) |
|||
September 30, |
December 31, |
||
2019 |
2018 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 128,161 |
$ 104,147 |
|
Accounts receivable, net |
370,725 |
202,139 |
|
Inventories, net |
174,386 |
94,090 |
|
Prepaid expenses and other current assets |
51,290 |
18,134 |
|
Total current assets |
724,562 |
418,510 |
|
Property, plant and equipment, net |
204,109 |
83,923 |
|
Right of use lease assets |
33,789 |
- |
|
Goodwill |
557,323 |
83,333 |
|
Other intangible assets, net |
1,064,048 |
63,582 |
|
Investments in associated companies |
91,937 |
21,316 |
|
Non-current deferred tax assets |
5,415 |
6,946 |
|
Other assets |
43,313 |
32,055 |
|
Total assets |
$ 2,724,496 |
$ 709,665 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 36,535 |
$ 670 |
|
Accounts and other payables |
173,722 |
92,754 |
|
Accrued compensation |
41,714 |
25,727 |
|
Accrued restructuring |
19,320 |
- |
|
Other current liabilities |
74,469 |
32,319 |
|
Total current liabilities |
345,760 |
151,470 |
|
Long-term debt |
826,503 |
35,934 |
|
Long-term lease liabilities |
24,259 |
- |
|
Non-current deferred tax liabilities |
212,673 |
10,003 |
|
Other non-current liabilities |
111,851 |
75,889 |
|
Total liabilities |
1,521,046 |
273,296 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2019 - |
17,731 |
13,338 |
|
Capital in excess of par value |
885,765 |
97,304 |
|
Retained earnings |
404,569 |
405,125 |
|
Accumulated other comprehensive loss |
(106,047) |
(80,715) |
|
Total Quaker shareholders' equity |
1,202,018 |
435,052 |
|
Noncontrolling interest |
1,432 |
1,317 |
|
Total equity |
1,203,450 |
436,369 |
|
Total liabilities and equity |
$ 2,724,496 |
$ 709,665 |
|
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Nine Months Ended September 30, |
|||
2019 |
2018 |
||
Cash flows from operating activities |
|||
Net income |
$ 16,568 |
$ 51,928 |
|
Adjustments to reconcile net income to net cash provided by operating |
|||
Amortization of deferred financing fees |
792 |
- |
|
Depreciation and amortization |
23,868 |
14,911 |
|
Equity in undistributed earnings of associated companies, net of dividends |
(129) |
2,658 |
|
Acquisition-related fair value adjustments related to inventory |
10,214 |
- |
|
Deferred compensation, deferred taxes and other, net |
(17,204) |
(898) |
|
Share-based compensation |
3,042 |
2,847 |
|
Gain on disposal of property, plant, equipment and other assets |
(111) |
(680) |
|
Insurance settlement realized |
(624) |
(680) |
|
Combination and other acquisition-related expenses, net of payments |
(14,218) |
(349) |
|
Restructuring and related activities |
24,045 |
- |
|
Pension and other postretirement benefits |
434 |
(1,113) |
|
Increase (decrease) in cash from changes in current assets and current liabilities, net of |
|||
Accounts receivable |
2,655 |
(14,029) |
|
Inventories |
1,376 |
(12,719) |
|
Prepaid expenses and other current assets |
(10,931) |
2,196 |
|
Change in restructuring liabilities |
(4,645) |
- |
|
Accounts payable and accrued liabilities |
344 |
6,824 |
|
Net cash provided by operating activities |
35,476 |
50,896 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(10,112) |
(8,815) |
|
Payments related to acquisitions, net of cash acquired |
(798,064) |
(500) |
|
Proceeds from disposition of assets |
75 |
803 |
|
Insurance settlement interest earned |
185 |
102 |
|
Net cash used in investing activities |
(807,916) |
(8,410) |
|
Cash flows from financing activities |
|||
Proceeds from term loans |
750,000 |
- |
|
Borrowings (repayments) on revolving credit facility, net |
85,966 |
(11,040) |
|
Borrowings (repayments) on other debt, net |
415 |
(478) |
|
Financing-related costs |
(23,747) |
- |
|
Dividends paid |
(15,003) |
(14,385) |
|
Stock options exercised, other |
733 |
(227) |
|
Distributions to noncontrolling affiliate shareholders |
- |
(834) |
|
Net cash provided by (used in) financing activities |
798,364 |
(26,964) |
|
Effect of foreign exchange rate changes on cash |
(1,889) |
(6,168) |
|
Net increase in cash, cash equivalents and restricted cash |
24,035 |
9,354 |
|
Cash, cash equivalents and restricted cash at the beginning of the period |
124,425 |
111,050 |
|
Cash, cash equivalents and restricted cash at the end of the period |
$ 148,460 |
$ 120,404 |
|
View original content to download multimedia:http://www.prnewswire.com/news-releases/quaker-houghton-announces-third-quarter-2019-results-300956856.html
SOURCE Quaker Houghton
Mary Dean Hall, Senior Vice President, Chief Financial Officer and Treasurer, investor@quakerhoughton.com, T. 1.610.832.4000